IHH Healthcare
IHH is one of the world’s largest healthcare networks, with 80 hospitals in 10 countries.
IHH Healthcare FY2025 net profit falls 21% to $682.67m
IHH Healthcare FY2025 net profit falls 21% to $682.67m
The decrease is due to unrealised currency translation losses from a stronger ringgit.
IHH Healthcare bets on Fortis stake for Indian expansion
It plans to add 2,000 hospital beds by 2028.
IHH Healthcare to expand network in India
The group’s shareholding now stands at 31.17% in Fortis and 62.73% in Malar.
IHH Healthcare’s net profit rises 15% to $149.13m in Q3
The group’s revenue rose 16% YoY to $1.6b (RM6.6b).
Parkway MediCentre Xintiandi in Shanghai
It is connected to Parkway Shanghai Hospital and the Parkway 百汇医疗 clinic network.
IHH Healthcare North Asia expands partnership with Prudential Hong Kong
Participating facilities include Gleneagles MediCentre or Parkway Shanghai Hospital.
IHH Healthcare launches new ambulatory care centre at Royal Square
It features two operating theatres and four endoscopy suites.
IHH Healthcare launches ‘Global Incubator Programme’ for startups
The group will work with selected participants in three-month development cycles.
Parkway Rehab @ Harbourfront opens in Singapore
The facility offers return-to-sport programmes and pain management.
What’s new with Turkiye’s Acıbadem Kent Hospital?
Its indoor area has more than doubled to 89,000 square metres.
IHH Healthcare’s net profit drops 29% to $105m in Q2
Revenue grew 3% to $1.5b (RM6.3b).
IHH Healthcare to drive digital transformation across key markets
The initiative focuses on Singapore, Malaysia, and India.
Fortis, Gleneagles Healthcare India partner to drive business growth
The entities will follow an “O&M Services” model.
IHH Healthcare North Asia launches AI Lab in Hong Kong
Key areas include remote heart and lung auscultation.
IHH Healthcare's net profit drops 33% to $121.3m in Q1
Revenue grew 6% YoY to $1.5b (RM 6.3b).
IHH Healthcare to fast-track shift to value-based care
The group monitors over 360 quality indicators across eight high-volume procedures.
Premier Integrated Labs unveils metabolomic testing in Malaysia
The platform can analyse more than 250 biomarkers from a single blood sample.
Most Read
1. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 2. Neurological disorders and aging boost brain-computer interface market 3. AJJ Medtech hits $8m order book with $3m green supply deal 4. Cardiac monitoring devices market to hit $37.88b by 2031 5. Nanomedicine market poised for double-digit growthResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation